Arcus Hunting, LLC, USA, the maker of Tink’s and Dead Down Wind hunting scents, announced a new licensing partnership to ...

Arcus Biosciences’ quemliclustat receives US FDA orphan drug designation to treat pancreatic cancer: Hayward, California Tuesday, July 15, 2025, 13:00 Hrs [IST] Arcus Bioscience ...

The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the ...

Simon Arcus has resigned as the chief executive of the Wellington Chamber of Commerce and parent organisation Business ...

Arcus provides support for bill payment and cash-in, cash-out services for billers, retailers, fintechs, and trad ...

Simon Arcus has resigned as the chief executive of the Chamber of Commerce and parent organisation Business Central, ...

Arcus Biosciences, Inc. (NYSE:RCUS) is one of the 12 Small Cap Stocks with High Upside Potential. On June 1, Arcus ...

"However, in serious cases, these are the tell-tale signs you should look out for." One indicator to look out for is a change ...

Arcus Biosciences’ Quemliclustat Receives Orphan Drug Designation for Pancreatic Cancer PRISM-1, the ongoing registrational, Phase 3 study evaluating quemliclustat plus chemotherapy as a first ...

Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today ...